Author: Sananez, Inés; Raiden, Silvina C.; Algieri, Silvia C.; Uranga, Macarena; GrisolÃa, Nicolás A.; Filippo, Daniela; De Carli, Norberto; Lalla, Sandra Di; Cairoli, Héctor; Chiolo, MarÃa J.; Meregalli, Claudia N.; Cohen, Emilia; Mosquera, Graciela; Marcó del Pont, MarÃa; Giménez, Lorena I.; Gregorio, Gabriela; Sarli, Mariam; Alcalde, Ana L.; Davenport, Carolina; Bruera, MarÃa J.; Simaz, Nancy; Pérez, Mariela F.; Nivela, Valeria; Bayle, Carola; Alvarez, Laura; Revetria, MarÃa; Tuccillo, Patricia; Agosta, MarÃa T.; Pérez, Hernán; Nova, Susana Villa; Suárez, Patricia; Takata, Eugenia M.; GarcÃa, Mariela; Lattner, Jorge; Rolón, MarÃa J.; Coll, Patricia; Salvatori, Melina; Piccardo, Claudio; Russo, Constanza; Varese, Augusto; Seery, Vanesa; Holgado, MarÃa P.; Polo, MarÃa L.; Ceballos, Ana; Nuñez, Myriam; Penedo, Juan MartÃn Gómez; Ferrero, Fernando; Geffner, Jorge; Arruvito, Lourdes
Title: A poor and delayed anti-SARS-CoV2 IgG response is associated to severe COVID-19 in children Cord-id: pdreia73 Document date: 2021_10_11
ID: pdreia73
Snippet: BACKGROUND: Most children and youth develop mild or asymptomatic disease during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, a very small number of patients suffer severe Coronavirus induced disease 2019 (COVID-19). The reasons underlying these different outcomes remain unknown. METHODS: We analyzed three different cohorts: children with acute infection (n=550), convalescent children (n=138), and MIS-C (multisystem inflammatory syndrome in children, n=42). IgG
Document: BACKGROUND: Most children and youth develop mild or asymptomatic disease during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, a very small number of patients suffer severe Coronavirus induced disease 2019 (COVID-19). The reasons underlying these different outcomes remain unknown. METHODS: We analyzed three different cohorts: children with acute infection (n=550), convalescent children (n=138), and MIS-C (multisystem inflammatory syndrome in children, n=42). IgG and IgM antibodies to the spike protein of SARS-CoV-2, serum-neutralizing activity, plasma cytokine levels, and the frequency of circulating Follicular T helper cells (cTfh) and plasmablasts were analyzed by conventional methods. FINDINGS: Fifty-eight percent of the children in the acute phase of infection had no detectable antibodies at the time of sampling while a seronegative status was found in 25% and 12% of convalescent and MIS-C children, respectively. When children in the acute phase of the infection were stratified according disease severity, we found that contrasting with the response of children with asymptomatic, mild and moderate disease, children with severe COVID-19 did not develop any detectable response. A defective antibody response was also observed in the convalescent cohort for children with severe disease at the time of admission. This poor antibody response was associated to both, a low frequency of cTfh and a high plasma concentration of inflammatory cytokines. INTERPRETATION: A weak and delayed kinetic of antibody response to SARS-CoV-2 together with a systemic pro-inflammatory profile characterize pediatric severe COVID-19. Because comorbidities are highly prevalent in children with severe COVID-19, further studies are needed to clarify their contribution in the weak antibody response observed in severe disease. FUNDING: National Agency for Scientific and Technological Promotion from Argentina (IP-COVID-19-0277 and PMO-BID-PICT2018-2548).
Search related documents:
Co phrase search for related documents- acute infection and adolescent child: 1, 2
- acute infection and low frequency: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- acute infection and low neutralizing: 1, 2, 3
- acute infection and low neutralizing activity: 1
- acute infection and lymph node: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- acute phase and admission time: 1, 2, 3, 4, 5, 6, 7
- acute phase and low frequency: 1
- acute phase and lymph node: 1, 2, 3, 4, 5
- acute respiratory syndrome and admission time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- acute respiratory syndrome and adolescent boy: 1
- acute respiratory syndrome and adolescent child: 1, 2, 3, 4, 5
- acute respiratory syndrome and localized area: 1
- acute respiratory syndrome and low frequency: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
- acute respiratory syndrome and low neutralizing: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- acute respiratory syndrome and low neutralizing activity: 1, 2, 3
- acute respiratory syndrome and lymph node: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35
- admission time and lymph node: 1, 2, 3
- adolescent child and low neutralizing: 1
- low frequency and lymph node: 1
Co phrase search for related documents, hyperlinks ordered by date